Renal cell carcinoma in kidney allografts: A case series from a single center

被引:75
作者
Barama, A [1 ]
St-Louis, G
Nicolet, V
Hadjeres, R
Daloze, P
机构
[1] Univ Montreal, Ctr Hosp, Hop Notre Dame, Dept Surg, Montreal, PQ, Canada
[2] Univ Montreal, Ctr Hosp, Hop Notre Dame, Dept Med,Nephrol Serv, Montreal, PQ, Canada
[3] Univ Montreal, Ctr Hosp, Hop Notre Dame, Dept Radiol, Montreal, PQ, Canada
[4] Univ Montreal, Ctr Hosp, Hop Notre Dame, Dept Pathol, Montreal, PQ, Canada
关键词
kidney transplantation; partial nephrectomy; post-transplant malignancy;
D O I
10.1111/j.1600-6143.2005.01099.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
In kidney transplant recipients, renal cell carcinoma (RCC) occurs either in the native kidney or, less frequently, in the grafted kidney. Here, we report a series of rare cases involving 5 patients from a single center who developed RCC in their grafts. The diagnosis was made serendipitously by ultrasound. The time lapse post-transplant varied from 4 to 17 years. Surgical treatment consisted of nephron-sparing surgery (NSS) in four cases and a secondary radical nephrectomy in one case. All tumors were less than 4 cm in diameter. The histopathology was clear cell type in four cases and papillary RCC in one case. Patients treated by NSS retained kidney function for 2 years or more, and none of them presented early neoplasia recurrence. In conclusion, NSS can be performed safely in grafted kidneys to treat incidental RCC. It prevents an immediate return to dialysis for patients.
引用
收藏
页码:3015 / 3018
页数:4
相关论文
共 17 条
[1]   SMALL RENAL PARENCHYMAL NEOPLASMS - FURTHER OBSERVATIONS ON GROWTH [J].
BOSNIAK, MA ;
BIRNBAUM, BA ;
KRINSKY, GA ;
WAISMAN, J .
RADIOLOGY, 1995, 197 (03) :589-597
[2]   Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response [J].
Bukur, J ;
Malenica, B ;
Huber, C ;
Seliger, B .
HUMAN IMMUNOLOGY, 2003, 64 (11) :1081-1092
[3]   Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: Impact of the amount of remaining renal tissue [J].
Clark, PE ;
Schover, LR ;
Uzzo, RG ;
Hafez, KS ;
Rybicki, LA ;
Novick, AC .
UROLOGY, 2001, 57 (02) :252-256
[4]   Risk factors for adult renal cell carcinoma [J].
Dhote, R ;
Thiounn, N ;
Debré, B ;
Vidal-Trecan, G .
UROLOGIC CLINICS OF NORTH AMERICA, 2004, 31 (02) :237-+
[5]   Successful surgical treatment of renal cell carcinoma in a transplanted kidney from a cadaveric donor: Report of a case [J].
Gunji, Y ;
Sakamoto, K ;
Yamada, K ;
Hamaguchi, K ;
Kashiwabara, H ;
Hori, S ;
Shimada, H ;
Suzuki, T ;
Ochiai, T .
SURGERY TODAY, 2001, 31 (04) :374-377
[6]   Rapamycin is an effective inhibitor of human renal cancer metastasis [J].
Luan, FL ;
Ding, RC ;
Sharma, VK ;
Chon, WJ ;
Lagman, M ;
Suthanthiran, M .
KIDNEY INTERNATIONAL, 2003, 63 (03) :917-926
[7]   Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience [J].
Morelon, E ;
Kreis, H .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) :52S-57S
[8]   PARTIAL NEPHRECTOMY FOR RENAL-CELL CARCINOMA [J].
NOVICK, AC .
UROLOGY, 1995, 46 (02) :149-152
[9]   History of urinary tract infection and risk of renal cell carcinoma [J].
Parker, AS ;
Cerhan, JR ;
Lynch, CF ;
Leibovich, BC ;
Cantor, KP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (01) :42-48
[10]   Cancers in renal transplant recipients [J].
Penn, I .
ADVANCES IN RENAL REPLACEMENT THERAPY, 2000, 7 (02) :147-156